Search Results

There are 15657 results for: content related to: Efficacy and Safety of Nonbiologic Immunosuppressants in the Treatment of Nonrenal Systemic Lupus Erythematosus: A Systematic Review

  1. You have free access to this content
    A renal mass in the setting of a nonrenal malignancy

    Cancer

    Volume 101, Issue 10, 15 November 2004, Pages: 2195–2201, Ricardo F. Sánchez-Ortiz, Lydia T. Madsen, Carlos E. Bermejo, Sijin Wen, Yu Shen, David A. Swanson and Christopher G. Wood

    Article first published online : 6 OCT 2004, DOI: 10.1002/cncr.20638

  2. You have free access to this content
    Inhibition of flucloxacillin tubular renal secretion by piperacillin

    British Journal of Clinical Pharmacology

    Volume 66, Issue 5, November 2008, Pages: 648–659, Cornelia B. Landersdorfer, Carl M. J. Kirkpatrick, Martina Kinzig, Jürgen B. Bulitta, Ulrike Holzgrabe and Fritz Sörgel

    Article first published online : 24 JUL 2008, DOI: 10.1111/j.1365-2125.2008.03266.x

  3. Assessment of the Impact of Renal Impairment on Systemic Exposure of New Molecular Entities: Evaluation of Recent New Drug Applications

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 3, March 2009, Pages: 305–311, Y Zhang, L Zhang, S Abraham, S Apparaju, T-C Wu, JM Strong, S Xiao, AJ Atkinson Jr, KE Thummel, JS Leeder, C Lee, GJ Burckart, LJ Lesko and S-M Huang

    Article first published online : 19 NOV 2008, DOI: 10.1038/clpt.2008.208

  4. You have free access to this content
    Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid

    British Journal of Clinical Pharmacology

    Volume 69, Issue 2, February 2010, Pages: 167–178, Cornelia B. Landersdorfer, Carl M. J. Kirkpatrick, Martina Kinzig, Jürgen B. Bulitta, Ulrike Holzgrabe, Ulrich Jaehde, Andreas Reiter, Kurt G. Naber, Michael Rodamer and Fritz Sörgel

    Article first published online : 23 OCT 2009, DOI: 10.1111/j.1365-2125.2009.03564.x

  5. You have free access to this content
    Biopsy-Diagnosed Renal Disease in Patients After Transplantation of Other Organs and Tissues

    American Journal of Transplantation

    Volume 10, Issue 9, September 2010, Pages: 2017–2025, A. Schwarz, H. Haller, R. Schmitt, M. Schiffer, C. Koenecke, C. Strassburg, F. Lehner, J. Gottlieb, C. Bara, J. U. Becker and V. Broecker

    Article first published online : 27 AUG 2010, DOI: 10.1111/j.1600-6143.2010.03224.x

  6. You have free access to this content
    Wait List Death and Survival Benefit of Kidney Transplantation Among Nonrenal Transplant Recipients

    American Journal of Transplantation

    Volume 10, Issue 11, November 2010, Pages: 2502–2511, J. R. Cassuto, P. P. Reese, S. Sonnad, R. D. Bloom, M. H. Levine, K. M. Olthoff, A. Shaked, A. Naji and P. Abt

    Article first published online : 26 OCT 2010, DOI: 10.1111/j.1600-6143.2010.03292.x

  7. You have free access to this content
    Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta-analysis

    Transplant International

    Volume 24, Issue 12, December 2011, Pages: 1198–1207, Simon R. Knight and Peter J. Morris

    Article first published online : 16 SEP 2011, DOI: 10.1111/j.1432-2277.2011.01335.x

  8. Biased estimates of nonrenal clearance

    Journal of Pharmaceutical Sciences

    Volume 90, Issue 7, July 2001, Pages: 960–966, Peter H. Hinderling

    Article first published online : 13 JUN 2001, DOI: 10.1002/jps.1047

  9. Preliminary Evaluation of a Particle-enhanced Turbidimetric Immunoassay (PETIA) for the Determination of Serum Cystatin C-Like Immunoreactivity in Dogs

    Veterinary Clinical Pathology

    Volume 30, Issue 2, June 2001, Pages: 86–90, Asger L. Jensen, Mads Bomholt and Lars Moe

    Article first published online : 5 MAR 2008, DOI: 10.1111/j.1939-165X.2001.tb00263.x

  10. Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation

    The Journal of Clinical Pharmacology

    Volume 52, Issue S1, January 2012, Pages: 91S–108S, Dr Ping Zhao, Dr Manuela de L. T. Vieira, Dr Joseph A. Grillo, Dr Pengfei Song, Dr Ta-Chen Wu, Dr Jenny H. Zheng, Dr Vikram Arya, Dr Eva Gil Berglund, Dr Arthur J. Atkinson Jr, Dr Yuichi Sugiyama, Dr K. Sandy Pang, Dr Kellie S. Reynolds, Dr Darrell R. Abernethy, Dr Lei Zhang, Dr Lawrence J. Lesko and Dr Shiew-Mei Huang

    Article first published online : 23 APR 2013, DOI: 10.1177/0091270011415528

  11. Vancomycin pharmacokinetics in acute renal failure: Preservation of nonrenal clearance

    Clinical Pharmacology & Therapeutics

    Volume 50, Issue 6, December 1991, Pages: 688–694, William L Macias, Bruce A Mueller and Sheila Kelly Scarim

    Article first published online : 3 DEC 1991, DOI: 10.1038/clpt.1991.208

  12. Impact of Glomerular Kidney Diseases on the Clearance of Drugs

    The Journal of Clinical Pharmacology

    Volume 52, Issue S1, January 2012, Pages: 23S–34S, Dr Melanie S. Joy

    Article first published online : 23 APR 2013, DOI: 10.1177/0091270011413895

  13. You have free access to this content
    Nonlinear pharmacokinetics of piperacillin in healthy volunteers – implications for optimal dosage regimens

    British Journal of Clinical Pharmacology

    Volume 70, Issue 5, November 2010, Pages: 682–693, Jürgen B. Bulitta, Martina Kinzig, Verena Jakob, Ulrike Holzgrabe, Fritz Sörgel and Nicholas H. G. Holford

    Article first published online : 14 JUL 2010, DOI: 10.1111/j.1365-2125.2010.03750.x

  14. You have free access to this content
    Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial

    Arthritis & Rheumatism

    Volume 62, Issue 1, January 2010, Pages: 211–221, Ellen M. Ginzler, David Wofsy, David Isenberg, Caroline Gordon, Laura Lisk and Mary-Anne Dooley

    Article first published online : 28 DEC 2009, DOI: 10.1002/art.25052

  15. Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5

    Clinical Pharmacology & Therapeutics

    Accepted manuscript online: 21 JAN 2016, Kenta Yoshida, Bo Sun, Lei Zhang, Ping Zhao, Darrell Abernethy, Thomas D. Nolin, Amin Rostami-Hodjegan, Issam Zineh and Shiew-Mei Huang

    DOI: 10.1002/cpt.337

  16. Clinical Relevance of Impaired Nonrenal Drug Clearance in ESRD

    Seminars in Dialysis

    Volume 23, Issue 5, September/October 2010, Pages: 482–485, Thomas D. Nolin and Mark L. Unruh

    Article first published online : 29 OCT 2010, DOI: 10.1111/j.1525-139X.2010.00775.x

  17. Hepatic Clearance, but Not Gut Availability, of Erythromycin Is Altered in Patients With End-Stage Renal Disease

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 4, April 2010, Pages: 465–472, H Sun, L A Frassetto, Y Huang and L Z Benet

    Article first published online : 20 JAN 2010, DOI: 10.1038/clpt.2009.247

  18. A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD

    Seminars in Dialysis

    Volume 28, Issue 4, July–August 2015, Pages: 325–329, Thomas D. Nolin

    Article first published online : 8 APR 2015, DOI: 10.1111/sdi.12374

  19. Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism and Transport

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 6, June 2008, Pages: 898–903, TD Nolin, J Naud, FA Leblond and V Pichette

    Article first published online : 2 APR 2008, DOI: 10.1038/clpt.2008.59

  20. The Effect of Chronic Renal Failure on Hepatic Drug Metabolism and Drug Disposition

    Seminars in Dialysis

    Volume 16, Issue 1, January 2003, Pages: 45–50, Albert W. Dreisbach and Juan J. L. Lertora

    Article first published online : 20 JAN 2003, DOI: 10.1046/j.1525-139X.2003.03011.x